Advertisement
Heart, Lung and Circulation
Letter to the Editor| Volume 16, ISSUE 2, P131, April 2007

Evaluation of Epsilon Amino-Caproic Acid (EACA) and Autologous Blood as Blood Conservation Strategies in Patients Undergoing Cardiac Surgery

      The recent article by Sharma and colleagues discusses the relative merits of epsilon amino-caproic acid (EACA) (Amicar) and autologous blood donation using intra-operative normovolaemic haemodilution. They used Pentastarch as the replacement fluid.
      • Sharma V.
      • Talwar S.
      • Choudhary S.K.
      • Lakshmy R.
      • Kale S.
      • Kumar A.S.
      Evaluation of epsilon amino-caproic acid (EACA) and autologous blood as blood conservation strategies in patients undergoing cardiac surgery.
      It should be noted that EACA is not universally available around the world. It has been withdrawn from sale from many countries including Australia and Europe. It is not licensed for use as a prophylactic treatment in cardiac surgery. Henry et al., in a Cochrane review of antifibrinolytic therapy showed the low rate of adverse events associated with EACA
      • Henry D.A.
      • Moxey A.J.
      • Carless P.A.
      • O’Connell D.
      • McClelland B.
      • Henderson K.M.
      • Sly K.
      • Laupacis A.
      • Fergusson D.
      Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
      but there have been no studies designed and powered to detect low rate events with EACA in cardiac surgery.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sharma V.
        • Talwar S.
        • Choudhary S.K.
        • Lakshmy R.
        • Kale S.
        • Kumar A.S.
        Evaluation of epsilon amino-caproic acid (EACA) and autologous blood as blood conservation strategies in patients undergoing cardiac surgery.
        Heart Lung Circ. 2006; 15: 261-265
        • Henry D.A.
        • Moxey A.J.
        • Carless P.A.
        • O’Connell D.
        • McClelland B.
        • Henderson K.M.
        • Sly K.
        • Laupacis A.
        • Fergusson D.
        Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
        Cochrane Database Syst Rev. 2001; : CD001886
        • Kuduvalli M.
        • Oo A.Y.
        • Newall N.
        • Grayson A.D.
        • Jackson M.
        • Desmond M.J.
        • Fabri B.M.
        • Rashid A.
        Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery.
        Eur J Cardiothorac Surg. 2005; 27: 592-598
        • Koch C.G.
        • Li L.
        • Duncan A.I.
        • Mihaljevic T.
        • Loop F.D.
        • Starr N.J.
        • Blackstone E.H.
        Transfusion in coronary artery bypass grafting is associated with reduced long-term survival.
        Ann Thorac Surg. 2006; 81: 1650-1657